The impact of cyclosporin formulation on clinical outcomes.
Holt
D W
DW
The Analytical Unit, Department of Cardiological Sciences, St George's Hospital Medical School, London, United Kingdom. d.holt@sghms.ac.uk
Johnston
A
A
D000284:Administration, Oral; D002626:Chemistry, Pharmaceutical; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016903:Drug Monitoring; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008657:Metabolic Clearance Rate; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine